Kaur M, Rai J, Bal BS, Kaur J. The impact of three combinations vildagliptin/metformin, vildagliptin/pioglitazone, and metformin/pioglitazone on glycemic control and atherogenic dyslipidemia in patients with Type 2 diabetes mellitus. Int J Basic Clin Pharmacol [Internet]. 2017 Jan. 27 [cited 2025 Sep. 27];3(5):902-7. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/1124